Sreeti Choudhury is an Associate Vice President of Analytical Sciences and Quality Control (QC) Operations at Castle Creek Biosciences, Inc. She has over 20 years of experience in managing analytical development and QC testing from early- to late-phase programs, global regulatory filing, including lipid-based targeted chemotherapy, vaccines, cell therapies and gene therapies.
Prior to joining Castle Creek, Dr. Choudhury was Head of Analytical Sciences at Spark Biotherapeutics, managing late-phase cell and gene therapy programs. She has held multiple leadership roles in many biotech companies including Amicus, Merck, Novartis, BMS, J&J and Baxter, where she actively contributed in BLA filing, driving projects from research and development to commercialization.
Dr. Choudhury earned a Ph.D. in Analytical Chemistry from Indian Institute of Technology, Kanpur, India and completed her post-doctorate fellowship at the University of Western Ontario, London, Ontario (Canada).
